The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
P53 expression in breast cancer
Abstract
Immunohistochemical evaluation of 200 primary breast cancers with the anti‐p53 mouse monoclonal antibody (MAb) PAb421 showed positivity in nuclei of malignant cells in 31 cases (15.5%). PAb421+ cases were significantly more frequently epidermal growth factor receptor (EGF‐R)‐positive (67.7%; p < 0.001) and estrogen receptor (ER)‐negative (73.3%; p < 0.001); they displayed surface histocompatibility class‐1 (80.6%; p < 0.01) and II (74.2%; p < 0.05) antigens. Low values for progesterone receptor (mean 67.20 ± 25.2 fmol/mg; p < 0.05) and a high number of cells positive for the proliferationassociated antigen Ki‐67 (log mean 6.88 ± 0.33; p < 0.01) were found in PAb421+ tumors as well as a high number of grade‐3 infiltrating duct carcinomas (70%; p = 0.01). Of the 200 cases of mammary carcinoma, 88 were further analyzed using another human specific anti‐p53 MAb PAb1801, and 40 (45.5%) were found positive. This MAb stained all the PAb421+ cases and was significantly associated with negative ER status (39.5%; p < 0.05) and high Ki‐67 scores (log mean 6.93 ± 0.24; p = 0.001). Analysis of PAb1801+/Pab421− cases for HLA antigens, EGF‐R and ER showed a phenotype similar to that of the p53−ve/ER+ carcinomas, except for the high Ki‐67 score. No differences in age of the patient, number of involved nodes, tumor size, ploidy or labelling index scores were evident between p53+ and − carcinomas. We concluded that p53 in mammary carcinomas is associated with ER‐negative, growth factor receptor‐positive, high‐grade tumors, and is a promising new parameter to evaluate the cellular biology and prognosis of breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gerdes, J., Lemke, H., Baisch, H., Wacker, H. H., Schwab, U., & Stein, H. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.133.4.1710 · Cited by 4,173
Bloom, H. J. G., & Richardson, W. W. (1957) · British Journal of Cancer · doi:10.1038/bjc.1957.43 · Cited by 2,925
Gerdes, J., Schwab, U., Lemke, H., & Stein, H. (1983) · International Journal of Cancer · doi:10.1002/ijc.2910310104 · Cited by 2,788
T antigen is bound to a host protein in SY40-transformed cells
LANE, D. P., & CRAWFORD, L. V. (1979) · Nature · doi:10.1038/278261a0 · Cited by 2,394
Kleer, C. G., Cao, Q., Varambally, S., Shen, R., Ota, I., Tomlins, S. A., Ghosh, D., Sewalt, R. G. A. B., Otte, A. P., Hayes, D. F., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1933744100 · Cited by 1,649
A Detergent‐trypsin method for the preparation of nuclei for flow cytometric DNA analysis
Vindeløv, L. L., Christensen, I. J., & Nissen, N. I. (1983) · Cytometry · doi:10.1002/cyto.990030503 · Cited by 1,639
Richard, J., Sainsbury, C., Needham, G., Farndon, J., Malcolm, A., & Harris, A. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90593-9 · Cited by 892
Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation
Parada, L. F., Land, H., Weinberg, R. A., Wolf, D., & Rotter, V. (1984) · Nature · doi:10.1038/312649a0 · Cited by 730
Participation of p53 cellular tumour antigen in transformation of normal embryonic cells
Eliyahu, D., Raz, A., Gruss, P., Givol, D., & Oren, M. (1984) · Nature · doi:10.1038/312646a0 · Cited by 717
BANKS, L., MATLASHEWSKI, G., & CRAWFORD, L. (1986) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1986.tb09919.x · Cited by 495
Growth regulation of a cellular tumour antigen, p53, in nontransformed cells
Reich, N. C., & Levine, A. J. (1984) · Nature · doi:10.1038/308199a0 · Cited by 494
EPIDERMAL-GROWTH-FACTOR RECEPTORS AND OESTROGEN RECEPTORS IN HUMAN BREAST CANCER
Sainsbury, J. R. C., Sherbet, G. V., Farndon, J. R., & Harris, A. L. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91385-6 · Cited by 492
Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer
Crawford, L. V., Pim, D. C., & Bulbrook, R. D. (1982) · International Journal of Cancer · doi:10.1002/ijc.2910300404 · Cited by 450
p63, a p53 Homologue, Is a Selective Nuclear Marker of Myoepithelial Cells of the Human Breast
Barbareschi, M., Pecciarini, L., Cangi, M. G., Macrì, E., Rizzo, A., Viale, G., & Doglioni, C. (2001) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200108000-00010 · Cited by 384
Specific interaction between the p53 cellular tumour antigen and major heat shock proteins
Pinhasi-Kimhi, O., Michalovitz, D., Ben-Zeev, A., & Oren, M. (1986) · Nature · doi:10.1038/320182a0 · Cited by 329
Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus
Mowat, M., Cheng, A., Kimura, N., Bernstein, A., & Benchimol, S. (1985) · Nature · doi:10.1038/314633a0 · Cited by 320
Metaplastic Carcinoma of the Breast : A Clinicopathologic Study of 29 Patients
Oberman, H. A. (1987) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198712000-00002 · Cited by 283
Monoclonal antibody analysis of p53 expression in normal and transformed cells
Yewdell, J. W., Gannon, J. V., & Lane, D. P. (1986) · Journal of Virology · doi:10.1128/jvi.59.2.444-452.1986 · Cited by 264
Brodsky, F. M., & Parham, P. (1982) · The Journal of Immunology · doi:10.4049/jimmunol.128.1.129 · Cited by 260
Mercer, W. E., Nelson, D., DeLeo, A. B., Old, L. J., & Baserga, R. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.20.6309 · Cited by 255
Growth fractions in breast cancers determined in situ with monoclonal antibody Ki-67.
Gerdes, J., Lelle, R. J., Pickartz, H., Heidenreich, W., Schwarting, R., Kurtsiefer, L., Stauch, G., & Stein, H. (1986) · Journal of Clinical Pathology · doi:10.1136/jcp.39.9.977 · Cited by 247
G�rtner, F., Schmitt, F. C., Preto, A., Reis-Filho, J. S., Simpson, P. T., & Martins, A. (2003) · Virchows Archiv · doi:10.1007/s00428-003-0859-2 · Cited by 235
Sainsbury, J. R., Malcolm, A. J., Appleton, D. R., Farndon, J. R., & Harris, A. L. (1985) · Journal of Clinical Pathology · doi:10.1136/jcp.38.11.1225 · Cited by 226
p53 transformation-related protein: Detection by monoclonal antibody in mouse and human cells
Dippold, W. G., Jay, G., DeLeo, A. B., Khoury, G., & Old, L. J. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.3.1695 · Cited by 201
Stein, H., Gatter, K. C., Asbahr, H., & Mason, D. Y. (1985) · PubMed · Cited by 196
Mucci, N. R., Akdas, G., Manely, S., & Rubin, M. A. (2000) · Human Pathology · doi:10.1053/hp.2000.7295 · Cited by 182
The cellular oncogene p53 can be activated by mutagenesis
Jenkins, J. R., Rudge, K., Chumakov, P., & Currie, G. A. (1985) · Nature · doi:10.1038/317816a0 · Cited by 169
Analysis of the gene coding for the murine cellular tumour antigen p53.
Bienz, B., Zakut-Houri, R., Givol, D., & Oren, M. (1984) · The EMBO Journal · doi:10.1002/j.1460-2075.1984.tb02110.x · Cited by 167
Rotter, V. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.9.2613 · Cited by 161
Due, C., Simonsen, M., & Olsson, L. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.16.6007 · Cited by 153
Overproduction of p53 antigen makes established cells highly tumorigenic
Eliyahu, D., Michalovitz, D., & Oren, M. (1985) · Nature · doi:10.1038/316158a0 · Cited by 146
de Fromentel, C. C., Chandrasekaran, K., May, P., May-Levin, F., Mouriesse, H., & Lemerle, J. (1987) · International Journal of Cancer · doi:10.1002/ijc.2910390211 · Cited by 131
Jakesz, R., Smith, C., Aitken, S. C., et al. (1984) · PubMed · Cited by 130
Growth factor requirements and basal phenotype of an immortalized mammary epithelial cell line.
DiRenzo, J., Signoretti, S., Nakamura, N., Rivera-Gonzalez, R., Sellers, W. R., Loda, M. F., & Brown, M. A. (2002) · PubMed · Cited by 129
Immunologically Distinct p53 Molecules Generated by Alternative Splicing
Arai, N., Nomura, D., Yokota, K., Wolf, D., Brill, E., Shohat, O., & Rotter, V. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.9.3232 · Cited by 128
Edwards, P. A. (1985) · British Journal of Cancer · doi:10.1038/bjc.1985.24 · Cited by 118
Different forms of p53 detected by monoclonal antibodies in non-dividing and dividing lymphocytes
Milner, J. (1984) · Nature · doi:10.1038/310143a0 · Cited by 116
The p53 cellular tumor antigen: gene structure, expression and protein properties
Oren, M. (1985) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(85)90015-0 · Cited by 109
The cellular protein p53 in human tumours.
Crawford, L. V., Pim, D. C., & Lamb, P. (1984) · PubMed · Cited by 104
Rotter, V., Abutbul, H., & Ben‐Ze'ev, A. (1983) · The EMBO Journal · doi:10.1002/j.1460-2075.1983.tb01543.x · Cited by 94
Expression of the p53 protein during the cell cycle of human peripheral blood lymphocytes
Mercer, W. E., & Baserga, R. (1985) · Experimental Cell Research · doi:10.1016/0014-4827(85)90233-2 · Cited by 92
Breast Cancer: Diagnosis and Management
Eiseman, B. (1985) · Archives of Surgery · doi:10.1001/archsurg.1985.01390280091020 · Cited by 82
P63 expression in normal, hyperplastic and malignant breast tissues
Wang, X., Mori, I., Tang, W., Nakamura, M., Nakamura, Y., Sato, M., Sakurai, T., & Kakudo, K. (2002) · Breast Cancer · doi:10.1007/bf02967592 · Cited by 78
Expression of the p53 oncogene in acute myeloblastic leukemia.
Smith, L. J., McCulloch, E. A., & Benchimol, S. (1986) · The Journal of Experimental Medicine · doi:10.1084/jem.164.3.751 · Cited by 52
Cited by
Miller, L. D., Smeds, J., George, J., Vega, V. B., Vergara, L., Ploner, A., Pawitan, Y., Hall, P., Klaar, S., Liu, E. T., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506230102 · Cited by 1,268
Increased expression of mutant forms of p53 oncogene in primary lung cancer
Iggo, R., Bartek, J., Lane, D., Gatter, K., Harris, A. L., & Bartek, J. (1990) · The Lancet · doi:10.1016/0140-6736(90)90801-b · Cited by 1,031
Prognostic Factors in Breast Cancer: College of American Pathologists Consensus Statement 1999
Fitzgibbons, P. L., Page, D. L., Weaver, D., Thor, A. D., Allred, D. C., Clark, G. M., Ruby, S. G., O'Malley, F., Simpson, J. F., Connolly, J. L., et al. (2000) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2000-124-0966-pfibc · Cited by 1,016
p53 mutations in colorectal cancer.
Rodrigues, N. R., Rowan, A., Smith, M. E., Kerr, I. B., Bodmer, W. F., Gannon, J. V., & Lane, D. P. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.19.7555 · Cited by 1,003
p53: oncogene or anti-oncogene?
Lane, D. P., & Benchimol, S. (1990) · Genes & Development · doi:10.1101/gad.4.1.1 · Cited by 795
Metadata
- Authors
- Cattoretti, G., Rilke, F., Andreola, S., D'Amato, L., & Delia, D.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 1988-02-15
- Volume
- 41
- Issue
- 2
- Pages
- 178-183
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2105298270
- Cited by
- 601
- References
- 44
- FWCI
- 9.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.